RGLS 21.43 Regulus Therapeutics Inc $RGLS Hit a 52 week

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
RGLS 21.43 Regulus Therapeutics Inc $RGLS Hit a 52 week high of 21.56 Currently at 21.43 +0.52 +2.49% With a day low of 20.51 and a total volume of 114,155.

RGLS Regulus Therapeutics Inc Recent Headline News

Gilead presents Harvoni data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:03AM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), ACHN: 12.45 (-0.40), CNAT: 7.08 (+0.02), MRK: 59.38 (+0.57), RGLS: 19.98 (-0.93), ABBV: 63.56 (-0.23), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

AbbVie presents HCV/HIV and liver transplant HCV data
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 9:07AM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), ACHN: 12.45 (-0.40), CNAT: 7.08 (+0.02), MRK: 59.38 (+0.57), RGLS: 19.98 (-0.93), ABBV: 63.56 (-0.23), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

Merck presents data from its investigational HCV combo
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:37AM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), ACHN: 12.45 (-0.40), CNAT: 7.08 (+0.02), MRK: 59.38 (+0.57), LGND: 57.27 (+1.59), RGLS: 19.98 (-0.93), ABBV: 63.56 (-0.23), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

Gilead presents data from three HCV drug combo studies
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 8:05AM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), ACHN: 12.45 (-0.40), CNAT: 7.08 (+0.02), LGND: 57.27 (+1.59), RGLS: 19.98 (-0.93), ABBV: 63.56 (-0.23), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

Regulus Slumps: RGLS Falls 5.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:53AM CST
Regulus has been witnessing a negative trend in its current year earnings estimate and its share price has been falling for past 24 hours
ACRX: 6.88 (+0.85), AUXL: 32.47 (-0.23), ADHD: 3.66 (-0.01), RGLS: 19.98 (-0.93)

Buyside Buzz on Gilead, Regulus From This Year's Liver Meeting
at The Street - Mon Nov 10, 9:40AM CST
Here's a quick sketch of the Wall Street gossip mill emerging from the 'Liver Meeting.'
GILD: 108.24 (+1.22), ACHN: 12.45 (-0.40), RGLS: 19.98 (-0.93), ABBV: 63.55 (-0.24)

Regulus Therapeutics (RGLS) Strong On High Relative Volume Today
at The Street - Mon Nov 10, 9:04AM CST
Trade-Ideas LLC identified Regulus Therapeutics (RGLS) as a strong on high relative volume candidate
RGLS: 19.98 (-0.93)

Merck triple therapy HCV candidate fails as a four-week regimen
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 6:49AM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), CNAT: 7.08 (+0.02), MRK: 59.38 (+0.57), LGND: 57.27 (+1.59), RGLS: 19.98 (-0.93), ABBV: 63.56 (-0.23), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

Bristol-Myers presents data on HCV Trio regimen
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 5:04PM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), CNAT: 7.08 (+0.02), MRK: 59.38 (+0.57), LGND: 57.27 (+1.59), RGLS: 19.98 (-0.93), ABBV: 63.55 (-0.24), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

Bristol-Myers presents data on shorter regimen HCV drug combo
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:37PM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), CNAT: 7.08 (+0.02), MRK: 59.38 (+0.57), LGND: 57.27 (+1.59), RGLS: 19.98 (-0.93), ABBV: 63.56 (-0.23), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

Achillion presents HCV data at The Liver Meeting
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:06PM CST

JNJ: 108.84 (+0.02), GILD: 108.24 (+1.22), ACHN: 12.45 (-0.40), CNAT: 7.08 (+0.02), MRK: 59.38 (+0.57), LGND: 57.27 (+1.59), RGLS: 19.98 (-0.93), ABBV: 63.56 (-0.23), BMY: 58.62 (-0.19), ENTA: 43.22 (-0.92)

Isis Pharmaceuticals Inc. Strikes Out on Its Own
Brian Orelli, The Motley Fool - Motley Fool - Fri Nov 07, 1:30PM CST
Until now, all of Isis Pharmaceuticals ' late-stage drugs involved partnerships with other companies. Kynamro, its only drug on the market, is sold by Sanofi , and phase 3 drug candidates ISIS-TTR, ISIS-SMN, and custirsen are respectively being...
BIIB: 324.02 (-3.85), ALNY: 99.10 (-0.08), ISIS: 51.04 (+3.81), OGXI: 2.15 (+0.02), TEVA: 58.18 (+0.14), RGLS: 19.98 (-0.93), GSK: 45.82 (+0.66), SNY: 47.08 (+0.89)

Regulus to Present at the Credit Suisse Healthcare Conference
PR Newswire - Thu Nov 06, 3:05PM CST
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Kleanthis G. Xanthopoulos, Ph.D., President and CEO of Regulus, will present a company overview at the Credit Suisse Healthcare Conference on Wednesday, November 12, 2014 at 10:30 a.m. MST. The conference is being held at the Arizona Biltmore in Phoenix, AZ.
RGLS: 19.98 (-0.93)

Insider Trading Alert - CBG, RGLS And WAB Traded By Insiders
at The Street - Thu Nov 06, 10:45AM CST
Stocks with insider trader activity include CBG, RGLS and WAB
CBG: 32.42 (+0.61), RGLS: 19.98 (-0.93), WAB: 89.53 (unch)

Regulus Therapeutics (RGLS) is in Overbought Territory: What's Next?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UST Grabs Italdesign: Driving Future Mobility with AI

Updated Category News Views 4

UST's Strategic Move Into Automotive's Future Wake up and smell the coffee, because UST is shaking up the automotive scene. They've just pulled off a major play by grabbing a majority stake in Italdesign. If that doesn't scream the next leap forward for the auto world, I don't know what does. UST isn't just buying a company; it's marrying Italdesign's legendary design...

Continue Reading
Lida Group Expands Global Modular Construction Services

Updated Category News Views 5

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Continue Reading
Hyosung Targets U.S. AI Power Market with Advanced SST

Updated Category News Views 3

Hyosung's Game-Changing Move in the AI Power Sector Guess what? The AI era's heating up, and it's dragging the power sector along for a wild ride. Hyosung Chairman Hyun-Joon Cho peered into that future and decided it's all-in time for the U.S. power market. With AI and data centers cranking up power demands like never before, those rickety old wires need an upgrade fast....

Continue Reading
AB SKF to Hold EGM, Spin Off Automotive Assets

Updated Category News Views 3

SKF's Extraordinary Meeting: A Pivotal Moment AB SKF, a heavyweight in the industrial technology sector, is summoning its shareholders for an Extraordinary General Meeting on October 1, 2026. The venue? The Elite Park Avenue Hotel in Gothenburg, Sweden—sounds fancy, but don't expect to hear a string quartet at this shindig. What's truly on the agenda is a critical...

Continue Reading
PBC 2026 Forum: Philanthropic Titans Collide in HK

Updated Category News Views 2

A Decade of Philanthropic Discourse The winds of change blew through Hong Kong’s West Kowloon Cultural District today, marking the tenth anniversary of the PBC 2026 forum—an event that’s got everyone from government bigwigs to sports icons chatting. Convened by The Hong Kong Jockey Club Charities Trust alongside the Institute of Philanthropy, this two-day journey is...

Continue Reading
Smart City Expo 2026: Innovations in Urban Living

Updated Category News Views 2

Peeling Back the Layers at Smart City Expo 2026 If you can't feel the pulse of change in urban landscapes, you're about to miss the bus. November's Smart City Expo World Congress (SCEWC) is the stage where cities showcase their flashy new upgrades—not just to look sleek but to make tangible, far-reaching impacts. From November 3 to 5, the city's Gran Via venue will host...

Continue Reading
Chef André Chiang Reimagines A Joy's Autumn Menu

Updated Category News Views 3

The Culinary World of Chef André Chiang There's a brand-new aroma wafting through Taiwan's dining scene, and it's got Chef André Chiang's signature all over it. Partnering with A Joy, a high-end buffet restaurant, this all-star chef is giving us something worth the chatter: an autumn menu that's as much about memories as it is about taste. We're looking at flavors that...

Continue Reading
Kean-NJCU Merger: A Strategic Educational Move

Updated Category News Views 3

The clock's ticked for Kean University and New Jersey City University, landing them into a fusion that's set tongues wagging across the education sector. This ain't just another day at the park—it’s a significant shift in the academic landscape that deserves a closer, sharper look. Behind the Curtains of Strategic Planning So, who’s behind the wheel charting this...

Continue Reading
West Texas Weather Shapes Home Design Decisions

Updated Category News Views 1

West Texas Weather: A Tough Customer for Home Builders You'd think building a house is a straightforward gig, but slap it down in West Texas, and we're talking a whole different ballgame. With its brutal heat, howling winds, and wild temperature swings, Odessa isn't just painting by numbers. It's where Mother Nature is your uninvited consultant on every single...

Continue Reading
CIMAMotor 2026: A Massive Gathering in Motorcycle Mecca

Updated Category News Views 3

Unprecedented Scale at CIMAMotor 2026 Come September, the 24th China International Motorcycle Trade Exhibition, also known as CIMAMotor 2026, is set to roar through the corridors of the Chongqing International Expo Center. With more than 1,000 exhibitors and over 3,000 vehicles on display, it’s clear this isn’t just another trade show—this is a full-blown spectacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Nokia Corporation Transfers Shares in Compliance with Incentives

Updated Category News Views 155

Nokia Corporation Transfers Shares to Incentive Plan Participants Nokia Corporation recently made significant changes regarding its shares as part of its ongoing commitment to its employees and incentive programs. A total of 3,935,723 shares held by the company were transferred on this occasion to participants involved in its equity-based incentive plans, executed...

Continue Reading
Innovative AI Solutions and Power Tools Unveiled by Bosch

Updated Category News Views 143

Transforming Job Sites: Bosch Unveils AI-Powered Solutions Bosch Power Tools is set to make a significant impact at this year’s World of Concrete tradeshow in Las Vegas. Visitors to the booth will have the unique opportunity to engage with live demonstrations of cutting-edge tools while customizing their work gear at an innovative sticker station. This year, Bosch is...

Continue Reading
Moberg Pharma and Karo Healthcare's Game-Changing Deal in Europe

Updated Category News Views 137

Moberg Pharma Enters Strategic Licensing Agreement in Europe Moberg Pharma AB (publ) has embarked on a pivotal licensing agreement with Karo Healthcare AB, focused on launching MOB-015 (Terclara) throughout Europe. This collaboration aims to leverage the strengths of both companies to make a significant impact across 19 European markets. Broad Market Reach and Launch...

Continue Reading
Northwest Biotherapeutics Expands Operations with Advent Acquisition

Updated Category News Views 288

Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd Northwest Biotherapeutics, Inc. (OTCQB: NWBO), a pioneering biotechnology firm dedicated to developing innovative DCVax® personalized immune therapies, has taken a significant step forward by entering into an acquisition agreement with Advent BioServices Ltd. This strategic move promises to...

Continue Reading
Celebrating the Spring Festival: Yiwu Prepares for Gala

Updated Category News Views 126

A Glimpse into Yiwu's Spring Festival Gala Preparations As the Lunar New Year approaches, Yiwu, a vital hub in China, offers a vibrant setting for impending celebrations. With its bustling trade market, Yiwu is in full swing, finalizing plans for the 2026 Spring Festival Gala, which highlights the essence of Chinese culture during one of the country's most treasured...

Continue Reading